Otic vesicle development

pathway activity — cross-omics
GO:0071599Cross-omicsPROTEIN-MS → DRUGCellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Otic vesicle development pathway is significantly associated with the drug response of multiple features, with the OVARY cohort showing a particularly strong set of associations.

The most reproducible pathway-associated features across cancer lineages are MN-64, Camptothecin, and SN-38, each associated with the pathway in up to 2 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The box plot shows the strongest association, MN-64 grouped by Otic vesicle development-low versus -high activity in OVARY.

Pathway-associated features by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner featureX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVARYMN-64 →-0.346-0.269.006.03232
LUNG_SCLCCamptothecin →-1.506-0.456.012.01931
LUNG_SCLCSN-38 →-1.733-0.456.006.01931
LUNG_SCLCBIBR-1532 →-0.799-0.456.003.01931
LARGE_INTESTINENavitoclax →+0.866+0.485.022.03731
LARGE_INTESTINE(5Z)-7-Oxozeaenol →-0.516-0.485.018.03731
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

MN-64 by Otic vesicle development activity — OVARY

Box plot of MN-64 in Otic vesicle development-low vs -high samples in OVARY.

Explore this box plot interactively →

Exploration